Autobio Diagnostics Co., Ltd.
603658
Clasificación en acciones
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Precio por acción
$5.15
Última sincronización: 2026-10-22
Capitalización bursátil
$2.94B
Cambio (1 día)
0.97%
Cambio (1 año)
-5.80%
País
CN
Comercio Autobio Diagnostics Co., Ltd. (603658)
Categoría
Healthcare
Ratio P/B de Autobio Diagnostics Co., Ltd. (603658)
Ratio P/B al October 2026 TTM: 2.27
Según los informes financieros más recientes y el precio de las acciones de Autobio Diagnostics Co., Ltd., el ratio P/B actual (TTM) es 2.27. Al final de 2024, el ratio P/B era 2.92.
Historial del ratio P/B de Autobio Diagnostics Co., Ltd. desde 2011 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 2.27 | -0.17% |
| 2025 | 2.27 | -22.45% |
| 2024 | 2.92 | -23.98% |
| 2023 | 3.84 | -17.13% |
| 2022 | 4.64 | 4.57% |
| 2021 | 4.44 | -53.90% |
| 2020 | 9.62 | -39.22% |
| 2019 | 15.83 | 57.82% |
| 2018 | 10.03 | -22.97% |
| 2017 | 13.02 | -2.75% |
| 2016 | 13.39 | 21.99% |
| 2015 | 10.98 | -30.81% |
| 2014 | 15.87 | -31.58% |
| 2013 | 23.19 | -32.83% |
| 2012 | 34.52 | -42.77% |
| 2011 | 60.32 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 4.5801 | 102.11% |
US
|
|
| 3.0725 | 35.59% |
US
|
|
| 31.4903 | 1,289.63% |
US
|
|
| 4.9326 | 117.67% |
CN
|
|
| 6.8081 | 200.43% |
US
|
